Enlargement at the European Court of Justice: Law,Language and Translation

The enlargement of the EU to 25 Member States in May 2005, followed by the accession of two more states in January 2007, raised a number of questions concerning the organisational structure of that Union—the sheer scale of the largest EU expansion to date highlighted the need to restructure EU institutions. For the European Court of Justice (ECJ), enlargement meant a huge influx of people to staff new divisions in the administrative hierarchy of the Court. This article describes the process and effects of enlargement at the ECJ, particularly in relation to translation and the language regime of that Court. Prior to the May 2004 and January 2007 enlargements there was a general perception among those working at the Court that enlargement would result in significant dislocation of life at that institution. In particular, it was felt that the translation directorate would not be able to cope with the addition of 11 ‘new’ languages to the list of official EU languages. The reality, however, was far from the disaster that many had predicted. That said, even a mere year following the May 2004 enlargement, a number of changes in the functioning and dynamics of that Court were already noticeable.     

‘Vials,ampoules and a bucketful of syringes’: the experience of the self-administration of hormonal drugs in IVF

During the process of in vitro fertilization (IVF), hormonal drugs are used to stimulate the woman's ovaries to produce multiple eggs. The injecting of the drugs is often performed by the women themselves outside of the clinical context, constituting a gendered burden of work that is rendered invisible by the dominant representations of treatment as undergone by couples and performed by doctors. Based on a series of interviews with women and couples who have undergone IVF unsuccessfully and who have ended treatment at least two years previously, this paper focuses on two aspects of the self-injection of hormonal drugs that emerged from the participants accounts: firstly, the gendered ways in which the drug regimen was experienced as compromising privacy and secondly, the strategic use of images of both illicit and medical drug use in the accounts. The paper argues that in spite of the dominant representation of IVF as a couples' technology, the IVF process is profoundly gendered, both in terms of bodily intervention and in the distribution of labour in the implementation of treatment; that the invisibility of the drug regimens from dominant representations of IVF can leave those undergoing treatment unprepared for some of the problems that the self-administration of the drugs can raise, particularly in terms of maintaining privacy; and finally, that images of the drug injection are mobilized strategically in the accounts to locate themselves within normative social reproductive standards. This highlights the extent to which the enduring ideological construction of proper womanhood as defined by motherhood continues to pose a dilemma for those who are involuntarily childless.     

Oral abuse of fentanyl patches (Duragesic): seven case reports

In order to increase the understanding regarding the oral abuse and potential toxicity of fentanyl patches seven cases were identified over a 3-year period where fentanyl, either alone or in combination with other factors, contributed to death following the oral abuse of Duragesic patches. The decedents comprised three females and four males with ages ranging from 20 to 51 years. Postmortem blood fentanyl concentrations were determined in all cases and ranged from 7 to 97 ng/mL. Two deaths were classified as a fentanyl overdose, three deaths were classified as a fentanyl and ethanol overdose, one death was considered a mixed drug intoxication and the remaining death was determined to be a combination of fentanyl and medical causes. These cases represent the largest reported series of deaths following the oral administration of transdermal fentanyl patches and provide detailed information on the potential for the abuse of transdermal Duragesic patches via this route. The postmortem blood fentanyl concentrations detected for each of the decedents demonstrate the potentially fatal blood concentrations that can arise after this relatively rare route of administration.